Last10K.com

Intellipharmaceutics International Inc. (IPCI) SEC Filing 20-F Annual report for the fiscal year ending Monday, February 27, 2017

Intellipharmaceutics International Inc.

CIK: 1474835 Ticker: IPCI

View differences made from one year to another to evaluate Intellipharmaceutics International Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Intellipharmaceutics International Inc..

Continue

Assess how Intellipharmaceutics International Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Intellipharmaceutics International Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations And Comprehensive Loss
Consolidated Statements Of Shareholders' Equity (deficiency)
Document And Entity Information
Note 1 - Nature Of Operations
Note 1 - Nature Of Operations (details)
Note 10 - Capital Stock
Note 10 - Capital Stock (details)
Note 11 - Options
Note 11 - Options (details 1)
Note 11 - Options (details 2)
Note 11 - Options (details 3)
Note 11 - Options (details Narrative)
Note 11 - Options (details)
Note 11 - Options (tables)
Note 12 - Deferred Share Units
Note 12 - Deferred Share Units (details Narrative)
Note 12 - Deferred Share Units (details)
Note 12 - Deferred Share Units (tables)
Note 13 - Restricted Share Units
Note 13 - Restricted Share Units (details Narrative)
Note 14 - Warrants
Note 14 - Warrants (details 1)
Note 14 - Warrants (details Narrative)
Note 14 - Warrants (details)
Note 14 - Warrants (tables)
Note 15 - Income Taxes
Note 15 - Income Taxes (details 1)
Note 15 - Income Taxes (details 2)
Note 15 - Income Taxes (details Narrative)
Note 15 - Income Taxes (details)
Note 15 - Income Taxes (tables)
Note 16 - Contingencies
Note 17 - Financial Instruments
Note 17 - Financial Instruments (details 1)
Note 17 - Financial Instruments (details 2)
Note 17 - Financial Instruments (details 3)
Note 17 - Financial Instruments (details 4)
Note 17 - Financial Instruments (details Narrative)
Note 17 - Financial Instruments (details)
Note 17 - Financial Instruments (tables)
Note 18 - Segmented Information
Note 18 - Segmented Information (details)
Note 18 - Segmented Information (tables)
Note 19 - Subsequent Event
Note 2 - Basis Of Presentation
Note 3 - Significant Accounting Policies
Note 3 - Significant Accounting Policies (details 1)
Note 3 - Significant Accounting Policies (details)
Note 3 - Significant Accounting Policies (policies)
Note 3 - Significant Accounting Policies (tables)
Note 4 - Accounts Receivable
Note 5 - Property And Equipment
Note 5 - Property And Equipment (details 1)
Note 5 - Property And Equipment (details)
Note 5 - Property And Equipment (tables)
Note 6 - Accrued Liabilities
Note 6 - Accrued Liabilities (details) - Accrued Liabilities
Note 6 - Accrued Liabilities (tables)
Note 7 - Due To Related Parties
Note 7 - Due To Related Parties (details 1)
Note 7 - Due To Related Parties (details)
Note 7 - Due To Related Parties (tables)
Note 8 - Employee Costs Payable
Note 8 - Employee Costs Payable (details)
Note 9 - Lease Obligations
Note 9 - Lease Obligations (details)
Note 9 - Lease Obligations (tables)
Ticker: IPCI
CIK: 1474835
Form Type: 20-F Annual Report
Accession Number: 0001654954-17-001523
Submitted to the SEC: Tue Feb 28 2017 4:38:45 PM EST
Accepted by the SEC: Tue Feb 28 2017
Period: Monday, February 27, 2017
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/ipci/0001654954-17-001523.htm